Skip to main content
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. — Investor Relations & Filings

Ticker · PCRX ISIN · US6951271005 LEI · 549300P56LERYBDHCF69 US Manufacturing
Open in API
Filings indexed 1,217 across all filing types
Latest filing 2020-03-13 Director's Dealing
Country US United States of America
Listing US PCRX

About Pacira BioSciences, Inc.

https://www.pacira.com/

Pacira BioSciences, Inc. is a pharmaceutical company that develops, commercializes, and manufactures non-opioid pain management and regenerative health solutions. The company's mission is to provide alternatives to opioids by delivering innovative, precise, and targeted therapies. Its products and research pipeline address a diverse range of needs, including postsurgical, chronic, and musculoskeletal pain. Pacira is also focused on developing advanced solutions, including gene therapy, to address unmet needs in pain management.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2020-03-13 English
FORM 4 SUBMISSION
Director's Dealing
2020-02-25 English
10-K
Annual Report FY 2019
2020-02-21 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 20, 2020, by Pacira BioSciences, Inc. It announces the issuance of a press release regarding the company's financial results for the fourth quarter and full year ended December 31, 2019. The document explicitly states that the press release is furnished as an exhibit and that the information is not deemed "filed" for certain regulatory purposes. The document is short (3477 characters) and primarily serves to announce the earnings release rather than containing the earnings data itself. According to the rules, such a document is best classified as an Earnings Release (ER) because it is the initial announcement of quarterly/periodical financial results, even though the full financial details are in the attached press release. The Form 8-K with an earnings press release is a standard format for earnings releases. Confidence is high due to the clear identification of the document as an earnings announcement and the presence of the earnings press release exhibit.
2020-02-20 English
SC 13G/A
Major Shareholding Notification
2020-02-14 English
SC 13G/A
Major Shareholding Notification
2020-02-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.